Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate, Alopexx in MAb Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Laureate, Alopexx in MAb Mfg. Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Pharma, Inc. has entered into a contract manufacturing agreement with Alopexx Pharmaceuticals to produce Alopexx’s mAb F598 antibody under cGMP conditions. This antibody will be used in clinical trials and later for commercial production for the treatment and prevention of Staphylococcus aureus infections.  
   
“We are pleased that Alopexx chose Laureate Pharma as their manufacturing partner,” said Robert J. Broeze, Ph. D., president and chief executive officer of Laureate. “We will closely collaborate with the Alopexx team and help them drive their product from development into the clinic.”
   
“Laureate Pharma has a track record of demonstrated expertise in biopharmaceutical manufacturing, including capabilities in both clinical and commercial-grade materials,” said Dr. Daniel Vlock, president and chief executive officer of Alopexx. “We look forward to our partnership with Laureate and advancing our antibody therapeutics program into the clinic.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics